|
|
Article: Clinical Trial Data for Perforomist(TM) Inhalation Solution to be Presented at ATS on May 20, 2008.
- Article from:
- PR Newswire
- Article date:
- May 16, 2008
CopyrightCOPYRIGHT 2008 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
- Data demonstrates safety and efficacy of first FDA-approved nebulized formoterol fumarate in patients with moderate to severe COPD -
NAPA, Calif., May 16 /PRNewswire/ -- Dey, L.P. announced today that three clinical data presentations will be given at the International Conference of the American Thoracic Society (ATS) on May 20, 2008 at the Metro Toronto Convention Center. One of the presentations details the effects on dyspnea and other COPD symptoms of using Perforomist(TM) Inhalation Solution, nebulized formoterol fumarate, adjunctively with tiotropium to treat COPD patients. The other two presentations compare the clinical effect of two types of drug ...